MedPath

Evaluation of the Possible Relationship Between Preeclampsia and Periodontal Disease

Conditions
Preeclampsia
Periodontal Disease
Registration Number
NCT03603236
Lead Sponsor
Recep Tayyip Erdogan University Training and Research Hospital
Brief Summary

The primary objective of the study is to assess the incidence and severity of the periodontal infection of patients with preeclampsia.

The secondary objective of the study is to analyze the relationship between preeclampsia and periodontal infection, using clinical, biochemical and microbiological methods.

Detailed Description

Preeclampsia is identified as an important cause for mother and newborn mortality. Inspite of extensive research, the exact etiological relations have not been established.

Periodontal disease is a subclinical and persistent infection source which induces the systemic inflammatory reactions and increases the risk of preeclampsia. It is believed that the results will set light to the etiology of preeclampsia and will help to develop strategies to prevent the disease.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
100
Inclusion Criteria
  • pregnant women with preeclampsia
    1. weeks of pregnant women with no history of preterm labor
Exclusion Criteria
  • Genitourinary infection,
  • pregnancy or pre-pregnancy hypertension,
  • HIV infection,
  • diabetes mellitus,
  • multiple pregnancy, preterm labor / low birth weight,
  • smoker and alcohol use history,
  • IVF pregnancy,
  • placental, cervical and uterine anomalies,
  • pregnancy with intrauterine growth retardation,
  • pregnancies with congenital or chromosomal fetal anomalies,
  • significant vaginal bleeding,
  • infertility stories,
  • drug addicts,
  • poor socioeconomic level

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
prostaglandin E21 Day

prostaglandin E2 levels will be evaulated in salivary, serum and placenta samples using ELISA test Normal value:29-97 pg / ml

IL-1beta (Interleukin 1 beta)1 day

IL-1beta levels will be evaulated in salivary, serum and placenta samples using ELISA test Normal value:3-227pg/ml

TNF-Alpha (Tumor necrosis factor -Alpha)1 day

TNF-Alpha levels will be evaulated in salivary, serum and placenta samples using ELISA test Normal value:42-203pg/ml

Secondary Outcome Measures
NameTimeMethod
Tannerella Forsythia1 Day

Presence of Tannerella Forsythia will be checked by rPCR method. Score:1 Present. Score 2: None

Porphyromonas gingivalis1 Day

Presence of Porphyromonas gingivalis will be checked by rPCR method. Score 1: Present Score 2: None Tannerella Forsythia (+,-)

Trial Locations

Locations (5)

Ege University Dentistry Faculty

🇹🇷

İzmir, Turkey

İzmir Health Sciences University, Tepecik Training and Research Hospital Department of Obstetrics and Gynecology

🇹🇷

İzmir, Turkey

Recep Tayyip Erdogan University Dentistry Faculty

🇹🇷

Rize, Turkey

Recep Tayyip Erdogan University Faculty of Medicine

🇹🇷

Rize, Turkey

Glaskow Dental School , School of Medicine University of Glasgow

🇬🇧

Glaskow, United Kingdom

Ege University Dentistry Faculty
🇹🇷İzmir, Turkey
: Nurcan Buduneli, Prof. Dr.
Contact
05326962525
nurcanbuduneli@yahoo.com
Önder Gürlek, Dr.
Contact
05057555888
dr.ondergurlek@hotmail.com
Pınar Gumus, Dr.
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.